Evidence map›Paper›PMID 30571262›Full record

GuidelineCirculation2018

2018 American Heart Association Focused Update on Advanced Cardiovascular Life Support Use of Antiarrhythmic Drugs During and Immediately After Cardiac Arrest: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.

Ashish R Panchal, Katherine M Berg, Peter J Kudenchuk, Marina Del Rios, Karen G Hirsch, Mark S Link, Michael C Kurz, Paul S Chan, José G Cabañas, Peter T Morley and 2 more

Open access · bronzeAbstract readPractice Guideline
In one paragraph

Guideline in Circulation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 7 pooled it
22.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 7 syntheses or guidelines pooled it, 184 citations in OpenAlex.

  1. Pooled it
  2. Antiarrhythmic drugs for cardiac arrest with a shockable rhythm and their effect on outcomes: a systematic review with meta-analysis.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Guideline
  6. Pooled it
  7. Guideline
  8. Trial
  9. Trial
  10. Article
  11. Review
  12. Article
  13. [Emergency pharmacotherapy in rhythmology].Herzschrittmachertherapie & Elektrophysiologie · 2026
    Review
  14. Article
  15. Article
  16. Observational
  17. Practical compendium of antiarrhythmic drugs: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Review
  18. Article
  19. Article
  20. Review

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Ashish R Panchal
Katherine M Berg
Peter J Kudenchuk
Marina Del Rios
Karen G Hirsch
Mark S Link
Michael C Kurz
Paul S Chan
José G Cabañas
Peter T Morley
Mary Fran Hazinski
Michael W Donnino
Christian Health Association of Nigeria · NGKaren Hospital · KEKatherine Hospital · AU

Funding

Hospital Enhancement of Resuscitation Outcomes for In-Hospital Cardiac Arrest (HER01HL123980 · NHLBI · SAINT LUKE'S HOSPITAL · PI CHAN, PAUL SHEUNG-YAN, NALLAMOTHU, BRAHMAJEE K · 2014 to 2018
$2.7M
Thiamine v placebo to improve oxygen consumption after in-hospital cardiac arrestK23HL128814 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI BERG, KATHERINE M · 2016 to 2021
$1.0M
NHLBI NIH HHS K23 HL128814NHLBI NIH HHS R01 HL123980
6 · The paper itself

Abstract

Antiarrhythmic medications are commonly administered during and immediately after a ventricular fibrillation/pulseless ventricular tachycardia cardiac arrest. However, it is unclear whether these medications improve patient outcomes. This 2018 American Heart Association focused update on advanced cardiovascular life support guidelines summarizes the most recent published evidence for and recommendations on the use of antiarrhythmic drugs during and immediately after shock-refractory ventricular fibrillation/pulseless ventricular tachycardia cardiac arrest. This article includes the revised recommendation that providers may consider either amiodarone or lidocaine to treat shock-refractory ventricular fibrillation/pulseless ventricular tachycardia cardiac arrest.

Indexed as

American Heart AssociationAmiodaroneAnti-Arrhythmia AgentsCardiopulmonary ResuscitationEmergency Medical ServicesHeart ArrestHumansLidocaineMagnesiumTachycardia, VentricularUnited StatesVentricular FibrillationAmiodaroneAnti-Arrhythmia AgentsLidocaineMagnesiumadvanced cardiac life support, adultAHA Scientific Statementsanti-arrhythmia agentscardiopulmonary resuscitationheart arresttachycardia, ventricularventricular fibrillation

Identifiers

PMID30571262
PMCPMC7324904
OpenAlexW2902181114

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.